trypanothione has been researched along with pmx 464 in 1 studies
Studies (trypanothione) | Trials (trypanothione) | Recent Studies (post-2010) (trypanothione) | Studies (pmx 464) | Trials (pmx 464) | Recent Studies (post-2010) (pmx 464) |
---|---|---|---|---|---|
187 | 0 | 47 | 13 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fairlamb, AH; König, J; Stevens, MF; Wells, G; Wyatt, PG; Wyllie, S | 1 |
1 other study(ies) available for trypanothione and pmx 464
Article | Year |
---|---|
Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.
Topics: Amide Synthases; Animals; Antineoplastic Agents; Benzothiazoles; Cysteine; Dose-Response Relationship, Drug; Glutathione; Hydroquinones; Protozoan Proteins; Spermidine; Thioredoxins; Time Factors; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2011 |